Press Room

Major Milestone in Communications Standards for Diabetes Devices

JDRF-funded program at the Centre for Global eHealth Innovation establishes open communication standards to enhance diabetes management and accelerate artificial pancreas research


JDRF in the Globe and Mail, November 25, 2014: For kids, research and new treatment options bring less discomfort and better outcomes

JDRF showcases advancements in CGM technology in making monitoring of glucose levels better and the new experimental encapsulated cell replacement therapy.


JDRF-Funded Islet Encapsulation Program Reaches Historic Milestone

First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy


JDRF On Canada AM

Dave Prowten and JDRF Youth Ambassador discuss Kids for a Cure Awareness Day with CTV Canada AM on Nov. 14


Type 1 Diabetes: What You Need To Know Now

EFFECTIVE DIABETES MANAGEMENT: Type 1 diabetes (T1D) strikes children and adults suddenly, and lasts a lifetime.


JDRF in the Globe and Mail, November 5, 2014: Improving the odds for expectant mothers

JDRF showcases advancements in T1D pregnancy care; highlighting JDRF CCTN and the CONCEPTT Trial, and exploring the challenges of managing T1D through pregnancy.


40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes

40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes (T1D) JDRF Ambassadors head to Parliament Hill to discuss the importance of funding research


Canadian Post-doctoral Fellowships Awarded in type 1 diabetes Research

Lilly Canada provided JDRF with $220,000 in 2013-2014 in support of the creation of a national clinical training program to enable young investigators to further engage in medical research associated with type 1 diabetes.


Giant leap against diabetes

Ability to produce embryonic stem cells will allow researchers to push faster toward cure


Diabetes researchers find faster way to create insulin-producing cells

University of British Columbia, in collaboration with BetaLogics Venture, a division of Janssen Research & Development, LLC, has published a study highlighting a protocol to convert stem cells into insulin-producing cells. The new procedure could be an important step in the fight against Type 1 ...


Lets turn type one into type none